Immunization, measles second dose in Latvia
Latvia: Immunization, measles second dose was 88.0% in 2024. ▼ Falling
Immunization, measles second dose in Latvia, 2000–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
Latvia recorded 88.0% for immunization, measles second dose in 2024.
The figure is down 4.3% on the previous year and down 1.1% over ten years.
Over the whole period, immunization, measles second dose in Latvia peaked at 99.0% in 2005 and was at its lowest, 85.0%, in 2021.
That places Latvia 78th out of 178 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently falling across the 25 years of available data.
Immunization, measles second dose in Latvia, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2000 | 90.0% | — |
| 2001 | 95.0% | +5.6% |
| 2002 | 96.0% | +1.1% |
| 2003 | 97.0% | +1.0% |
| 2004 | 98.0% | +1.0% |
| 2005 | 99.0% | +1.0% |
| 2006 | 99.0% | +0.0% |
| 2007 | 98.0% | -1.0% |
| 2008 | 94.0% | -4.1% |
| 2009 | 92.0% | -2.1% |
| 2010 | 93.0% | +1.1% |
| 2011 | 92.0% | -1.1% |
| 2012 | 92.0% | +0.0% |
| 2013 | 92.0% | +0.0% |
| 2014 | 89.0% | -3.3% |
| 2015 | 92.0% | +3.4% |
| 2016 | 89.0% | -3.3% |
| 2017 | 89.0% | +0.0% |
| 2018 | 94.0% | +5.6% |
| 2019 | 96.0% | +2.1% |
| 2020 | 94.0% | -2.1% |
| 2021 | 85.0% | -9.6% |
| 2022 | 86.0% | +1.2% |
| 2023 | 92.0% | +7.0% |
| 2024 | 88.0% | -4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 95.8% | 90.0% | 99.0% | 10 |
| 2010s | 91.8% | 89.0% | 96.0% | 10 |
| 2020s | 89.0% | 85.0% | 94.0% | 5 |
Countries ranked near Latvia
- 78 Azerbaijan 88.0% compare
- 78 Palau 88.0% compare
- 78 Seychelles 88.0% compare
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0264 units per person (2025)
- Population ages 05-09, male, annual growth rate -4.21 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0285 units per person (2025)
- Population ages 10-14, female, annual growth rate 2.1 % change on previous year (2025)
Frequently asked questions
- What is immunization, measles second dose in Latvia?
- Immunization, measles second dose in Latvia was 88.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Latvia?
- The highest recorded value was 99.0% in 2005.
- What is the lowest immunization, measles second dose recorded in Latvia?
- The lowest recorded value was 85.0% in 2021.
- How does Latvia rank for immunization, measles second dose?
- Latvia ranks 78th out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in Latvia?
- Over the last ten years it is down 1.1%. The long-run trend across the full record is falling.
- Where does this Latvia data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.